PlainPharmaWatch

CMS Open Payments · Tool

Virtual Incision Corporation vs Nuwellis, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Virtual Incision Corporation has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,423, versus 1,104 for the other company. Its single largest recorded recipient represents 0.3% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Virtual Incision Corporation
HHI 1,423 · top recipient 0.3%
Ranked #890 of 1,838 companies by HHI
Nuwellis, Inc.
HHI 1,104 · top recipient 0.2%
Ranked #991 of 1,838 companies by HHI

Payment Overview

Total Payments
$447.4K
% of Industry
0.0%
Transactions
683
Avg per Transaction
$655.10
Recipients
683
Avg per Recipient
$655.10
Payment Types
3
Top Payment Type
Consulting Fee
Company B

Nuwellis, Inc.

Total Payments
$447.8K
% of Industry
0.0%
Transactions
332
Avg per Transaction
$1.3K
Recipients
251
Avg per Recipient
$1.8K
Payment Types
6
Top Payment Type
Compensation for Services Other Than Consulting

Highlighted values indicate the higher figure for each metric.

Total payments compared

Virtual Incision Corporation vs Nuwellis, Inc. - total reported payments in CMS Open Payments PY2024

Nuwellis, Inc.$447.8KVirtual Incision Corporation$447.4K

Payment Types Breakdown

Virtual Incision Corporation

Consulting Fee $361.5K

80.8%

Travel and Lodging $58.3K

13.0%

Food and Beverage $27.7K

6.2%

Nuwellis, Inc.

Compensation for Services Other Than Consulting $115.2K

25.7%

Consulting Fee $76.3K

17.0%

Education $27.8K

6.2%

Travel and Lodging $13.0K

2.9%

Food and Beverage $9.4K

2.1%

Space Rental or Facility Fees $1.0K

0.2%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Virtual Incision Corporation

  1. 1

    DMITRY OLEYNIKOV

    $140,684.00 · 168 txns

  2. 2

    MICHAEL JOBST

    $79,693.00 · 61 txns

  3. 3

    GREGORY HEIDRICK

    $24,103.00 · 12 txns

  4. 4

    NADIA GOMEZ

    $19,758.00 · 10 txns

  5. 5

    MARTIN MARTINO

    $16,206.00 · 7 txns

Nuwellis, Inc.

  1. 1

    John Lynn Jefferies

    $44,500.00 · 8 txns

  2. 2

    Maria Rosa Costanzo

    $43,090.67 · 4 txns

  3. 3

    University Of Alabama Hospital

    $30,714.68 · 9 txns

  4. 4

    The Childrens Hospital Of Alabama

    $25,000.00 · 2 txns

  5. 5

    Linda Hart

    $17,359.50 · 5 txns

Summary Comparison

Metric Virtual Incision Corporation Nuwellis, Inc.
Total Payments $447.4K $447.8K
% of Industry Total 0.0% 0.0%
Transaction Count 683 332
Avg per Transaction $655.10 $1.3K
Recipient Count 683 251
Avg per Recipient $655.10 $1.8K
Payment Type Count 3 6
Top Payment Type Consulting Fee Compensation for Services Other Than Consulting

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.